Canadian Institute Of Orthopaedics Endorses Swiss Medica's 024 Essential Oil Pain Neutralizer.TORONTO -- Swiss Medica medica (māˑ·dē·k (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :SWME) is pleased to announce that the Canadian Institute of Orthopaedics has endorsed the Company's 024(TM) Essential Oil Pain Neutralizer. The Institute has sixteen clinics across Canada Across Canada was an afternoon program that formerly aired on The Weather Network. The segment ran from early 1999 until mid 2002. The show ran from 3:00PM ET until 7:00 PM ET. , from Montreal to Vancouver and throughout Ontario, which service approximately 1,000 patients per month. Dr. Kamille Ramsundar, an orthopedic surgeon with the Canadian Institute of Orthopaedics, said, "We have tested the 024 product over a 30-day period on about 150 patients and had about an 85-percent success rate. Based upon the results that I've seen with our own patients, I would be happy to endorse 024." Swiss Medica President and Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. , Grant Johnson said, "We are honored to have the 024(TM) Essential Oil Pain Neutralizer recognized and endorsed by this widely influential and highly respected body of medical practitioners." About Swiss Medica Inc. Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com and www.024zone.com Swiss Medica's flagship product A primary product of a company, which is typically why the company was founded and/or what made it well known. For example, MS-DOS, Windows and the Microsoft Office suite have been flagship products of Microsoft. CorelDRAW is a flagship product of Corel Corporation. , the 024(TM) Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The 024(TM) pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , Canada and in Europe. O24 is widely available throughout Canada in leading pharmacies and natural food stores. It is available in the United States and elsewhere by visiting www.024zone.com, for ordering details and store locators. Forward-looking statements in this news release are made pursuant to the "Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " provisions of the United States Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion